These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2506609)

  • 21. Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects.
    Kahn RS; Kalus O; Wetzler S; Cahn W; Asnis GM; van Praag HM
    Psychiatry Res; 1990 Aug; 33(2):189-98. PubMed ID: 2243896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats.
    Freo U; Soncrant TT; Ricchieri GL; Wozniak KM; Larson DM; Rapoport SI
    Brain Res; 1990 Mar; 511(2):209-16. PubMed ID: 2334843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of trazodone and m-chlorophenylpiperazine (m-CPP) on acute dependence in mice.
    Valeri P; Pimpinella G; Troiani MP; Morrone LA; Romanelli L
    Brain Res Bull; 1991 May; 26(5):799-802. PubMed ID: 1933399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of trazodone and bicuculline on conditioning-avoidance in the rat.
    De Marino V; Pisanti N; Capone D
    Boll Soc Ital Biol Sper; 1986 Jul; 62(7):871-5. PubMed ID: 3790326
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
    Kennett GA; Curzon G
    Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.
    Pigott TA; Hill JL; Grady TA; L'Heureux F; Bernstein S; Rubenstein CS; Murphy DL
    Biol Psychiatry; 1993 Jan; 33(1):3-14. PubMed ID: 8420593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological investigations on etoperidone, a new psychotropic agent.
    Lisciani R; Baldini A; de Feo G; Silvestrini B
    Arzneimittelforschung; 1978; 28(3):417-23. PubMed ID: 580751
    [No Abstract]   [Full Text] [Related]  

  • 28. Piperazinylalkyl heterocycles as potential antipsychotic agents.
    Scott MK; Baxter EW; Bennett DJ; Boyd RE; Blum PS; Codd EE; Kukla MJ; Malloy E; Maryanoff BE; Maryanoff CA
    J Med Chem; 1995 Oct; 38(21):4198-210. PubMed ID: 7473547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of trazodone metabolism in its inhibitory action on avoidance response.
    Sansone M; Melzacka M; Vetulani J
    Pharmacol Biochem Behav; 1985 Jul; 23(1):137-40. PubMed ID: 4034616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of depressant action of trazodone on avoidance behaviour by its metabolite m-chlorophenylpiperazine.
    Sansone M; Melzacka M; Hano J; Vetulani J
    J Pharm Pharmacol; 1983 Mar; 35(3):189-90. PubMed ID: 6132983
    [No Abstract]   [Full Text] [Related]  

  • 31. Interactions of trazodone with serotonin neurons and receptors.
    Fuller RW; Snoddy HD; Cohen ML
    Neuropharmacology; 1984 May; 23(5):539-44. PubMed ID: 6429562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion.
    Ulrichsen J; Partilla JS; Dax EM
    Psychopharmacology (Berl); 1992; 107(2-3):229-35. PubMed ID: 1352053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.
    Wadenberg ML; Kapur S; Soliman A; Jones C; Vaccarino F
    Psychopharmacology (Berl); 2000 Jul; 150(4):422-9. PubMed ID: 10958084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine.
    Li AA; Marek GJ; Hand TH; Seiden LS
    Eur J Pharmacol; 1990 Feb; 177(3):137-44. PubMed ID: 2311675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trazodone, a central serotonin antagonist and agonist.
    Maj J; Palider W; Rawłów
    J Neural Transm; 1979; 44(3):237-48. PubMed ID: 438809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of two non tricyclic antidepressant drugs on [14C]5-hydroxytryptamine uptake by rat platelets.
    Wielosz M; Dall'olio A; de Gaetano G; Garattini S
    J Pharm Pharmacol; 1977 Sep; 29(9):546-9. PubMed ID: 21259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats.
    Broekkamp CL; Garrigou D; LLoyd KG
    Pharmacol Biochem Behav; 1980 Nov; 13(5):643-6. PubMed ID: 6969405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.
    Robertson DW; Bloomquist W; Wong DT; Cohen ML
    Life Sci; 1992; 50(8):599-605. PubMed ID: 1736030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Helsley S; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.